Table 3. CpG methylation in the INS promoter in T2D patients and controls.

	T2D Patients (N = 132)	T2D CONTROLS (N = 186)
	DNA methylation (%)		p
CpG -19	47±11	54±10	2.10−6
CpG -69	88±11	88±6	0.22
CpG -102	68±18	64±13	0.01
CpG -135	58±10	55±10	0.06
CpG -180	57±19	61±11	0.14
CpG -206	91±10	93±7	0.79
CpG -234	57±9	51±6	5.10−8

Results are expressed as mean ± sd. P-values are calculated by Wilcoxon rank sum test.